{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:02:58Z","timestamp":1765609378134},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/olq.0b013e31818b64ac","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T07:10:01Z","timestamp":1224486601000},"page":"S66-S75","source":"Crossref","is-referenced-by-count":43,"title":["The Program Cost and Cost-Effectiveness of Screening Men for Chlamydia to Prevent Pelvic Inflammatory Disease in Women"],"prefix":"10.1097","volume":"35","author":[{"given":"Thomas L.","family":"Gift","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte K.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne M.","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis A.","family":"Rietmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Schillinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210213","first-page":"1","article-title":"Summary of notifiable diseases\u2013United States, 2006.","volume":"55","author":"McNabb","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-12-20210213","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among Am youth: incidence and prevalence estimates, 2000.","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"R3-12-20210213","first-page":"166","article-title":"Sexually transmitted disease surveillance 2006.","year":"2007"},{"key":"R4-12-20210213","first-page":"1017","article-title":"Sexually Transmitted Diseases.","author":"Paavonen","year":"2008"},{"key":"R5-12-20210213","first-page":"325","article-title":"Guide to Clinical Preventive Services.","year":"2002"},{"key":"R6-12-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2006.","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-12-20210213","article-title":"AMA Guidelines for Adolescent Preventive Services (GAPS).","author":"Elster","year":"1994"},{"key":"R8-12-20210213","first-page":"575","article-title":"Sexually Transmitted Diseases.","author":"Stamm","year":"2008"},{"key":"R9-12-20210213","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/01.olq.0000235149.41948.fa","article-title":"The direct medical cost of epididymitis and orchitis: Evidence from a study of insurance claims.","volume":"33","author":"Gift","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R11-12-20210213","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00007435-200010000-00005","article-title":"Cost-effectiveness of screening programs for Chlamydia trachomatis.","volume":"27","author":"Welte","year":"2000","journal-title":"Sex Transm Dis"},{"key":"R12-12-20210213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bmj.39262.683345.AE","article-title":"Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.","volume":"335","author":"Roberts","year":"2007","journal-title":"BMJ"},{"key":"R13-12-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4733.2006.00075.x","article-title":"Systematic screening for Chlamydia trachomatis: Estimating cost-effectiveness using dynamic modeling and Dutch data.","volume":"9","author":"de Vries","year":"2006","journal-title":"Value Health"},{"key":"R14-12-20210213","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/sti.2006.024364","article-title":"The cost effectiveness of opportunistic chlamydia screening in England.","volume":"83","author":"Adams","year":"2007","journal-title":"Sex Transm Infect"},{"key":"R16-12-20210213","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.olq.0000149670.11953.ca","article-title":"Prevalence of Chlamydia trachomatis infection among men screened in 4 US cities.","volume":"32","author":"Schillinger","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R20-12-20210213","first-page":"105","article-title":"Gonorrhea Transmission Dynamics and Control.","author":"Hethcote","year":"1984"},{"key":"R21-12-20210213","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1098\/rstb.1999.0431","article-title":"The transmission dynamics of gonorrhoeae: modelling the reported behaviour of infected patients from Newark, New Jersey.","volume":"354","author":"Garnett","year":"1999","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"R22-12-20210213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-141-7-200410050-00006","article-title":"Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.","volume":"141","author":"Hu","year":"2004","journal-title":"Ann Intern Med"},{"key":"R23-12-20210213","first-page":"149","article-title":"Vaccines for the 21st Century: A Tool for Decisionmaking.","year":"1999"},{"key":"R24-12-20210213","first-page":"276","article-title":"Cost-Effectiveness in Health and Medicine.","author":"Siegel","year":"1996"},{"key":"R25-12-20210213","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/1403510","article-title":"Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example.","volume":"62","author":"Blower","year":"1994","journal-title":"Int Stat Rev"},{"key":"R28-12-20210213","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00007435-200306000-00004","article-title":"Partner notification: low coverage for gonorrhea, chlamydia, and HIV.","volume":"30","author":"Golden","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R29-12-20210213","first-page":"116","article-title":"Chlamydia Prevalence Monitoring Project Annual Report 2006.","year":"2007"},{"key":"R30-12-20210213","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-147-2-200707170-00007","article-title":"A population based survey of chlamydia and gonorrhea among persons 14\u201339 years of age in the United States, National Health and Nutrition Examination Survey (NHANES) 1999\u20132002.","volume":"147","author":"Datta","year":"2007","journal-title":"Ann Intern Med"},{"key":"R31-12-20210213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/OLQ.0b013e31816d1f55","article-title":"Cost and effectiveness of chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.","volume":"35","author":"Nevin","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R32-12-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amepre.2006.03.012","article-title":"Priorities among effective clinical preventive services.","volume":"31","author":"Maciosek","year":"2006","journal-title":"Am J Prev Med"},{"key":"R33-12-20210213","first-page":"74","article-title":"The state of health care quality 2005.","year":"2007"},{"key":"R34-12-20210213","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/aje\/kwh162","article-title":"Indirect estimation of chlamydia screening coverage using public health surveillance data.","volume":"160","author":"Levine","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R35-12-20210213","first-page":"718","article-title":"The social organization of sexuality.","author":"Laumann","year":"1994"},{"key":"R36-12-20210213","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.1996.03540210045032","article-title":"Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships.","volume":"276","author":"Quinn","year":"1996","journal-title":"JAMA"},{"key":"R37-12-20210213","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00007435-199601000-00008","article-title":"Mathematical modeling of epidemic syphilis transmission.","volume":"23","author":"Oxman","year":"1996","journal-title":"Sex Transm Dis"},{"key":"R38-12-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00007435-199701000-00009","article-title":"The role of sexual partnership networks in the epidemiology of gonorrhea.","volume":"24","author":"Ghani","year":"1997","journal-title":"Sex Transm Dis"},{"key":"R39-12-20210213","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: The case for screening.","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"R40-12-20210213","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2105\/AJPH.70.9.997","article-title":"Self-reported behavior patterns of patients attending a sexually transmitted disease clinic.","volume":"70","author":"Kramer","year":"1980","journal-title":"Am J Public Health"},{"key":"R41-12-20210213","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/oxfordjournals.aje.a008926","article-title":"Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations.","volume":"144","author":"Kretzschmar","year":"1996","journal-title":"Am J Epidemiol"},{"key":"R42-12-20210213","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/153.1.90","article-title":"Comparative model-based analysis of screening programs for Chlamydia trachomatis infections.","volume":"153","author":"Kretzschmar","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R43-12-20210213","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/428287","article-title":"The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: A 5-year follow-up study.","volume":"191","author":"Molano","year":"2005","journal-title":"J Infect Dis"},{"key":"R44-12-20210213","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1258\/095646202762226092","article-title":"The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.","volume":"13","author":"Morr\u00e9","year":"2002","journal-title":"Int J STD AIDS"},{"key":"R45-12-20210213","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-124-4-199602150-00002","article-title":"Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.","volume":"124","author":"Magid","year":"1996","journal-title":"Ann Intern Med"},{"key":"R46-12-20210213","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/jama.1987.03390150086041","article-title":"Chlamydia trachomatis infections in the United States. What are they costing us?","volume":"257","author":"Washington","year":"1987","journal-title":"JAMA"},{"key":"R47-12-20210213","first-page":"456","article-title":"Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.","volume":"100","author":"Wiesenfeld","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"suppl 2","key":"R48-12-20210213","first-page":"65","article-title":"Low rate of pelvic inflammatory disease (PID) among women with incident Chlamydia trachomatis (CT) infection.","volume":"12","author":"Douglas","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R49-12-20210213","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/sti.2005.017186","article-title":"Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: The Uppsala women's cohort study.","volume":"82","author":"Low","year":"2006","journal-title":"Sex Transm Infect"},{"key":"R50-12-20210213","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00007435-199910000-00002","article-title":"Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.","volume":"26","author":"Bachmann","year":"1999","journal-title":"Sex Transm Dis"},{"key":"R51-12-20210213","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1086\/511421","article-title":"Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: Evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines.","volume":"44","author":"Geisler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R52-12-20210213","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/JCM.42.7.3041-3045.2004","article-title":"Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.","volume":"42","author":"Gaydos","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R53-12-20210213","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/JCM.38.12.4382-4386.2000","article-title":"Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men.","volume":"38","author":"Johnson","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R54-12-20210213","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.39.3.1008-1016.2001","article-title":"Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.","volume":"39","author":"Van Der Pol","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R55-12-20210213","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JCM.02620-05","article-title":"Detection of Chlamydia trachomatis by nucleic acid amplification testing: Our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.","volume":"44","author":"Schachter","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R56-12-20210213","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007435-199802000-00008","article-title":"Screening women for Chlamydia trachomatis in family planning clinics.","volume":"25","author":"Howell","year":"1998","journal-title":"Sex Transm Dis"},{"key":"R57-12-20210213","first-page":"19","article-title":"2001 sexualy transmitted diseases laboratory test method survey [report].","year":"2002"},{"key":"R58-12-20210213","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007435-198904000-00004","article-title":"The incremental cost of screening, diagnosis, and treatement of gonorrhea and gonorrhea and chlamydia in a family planning clinic.","volume":"16","author":"Begley","year":"1989","journal-title":"Sex Transm Dis"},{"key":"R59-12-20210213","first-page":"800","article-title":"2001 Drug Topics red Book, 105th ed.","year":"2001"},{"key":"R60-12-20210213","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.olq.0000175414.80023.59","article-title":"A cost-effectivenes analysis of interventions to increase repeat testing in patients treated for gonorrhea of chlamydia at public sexually transmitted disease clinics.","volume":"32","author":"Gift","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R61-12-20210213","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007435-200305000-00001","article-title":"A refined estimate of the average lifetime cost of pelvic inflammatory disease.","volume":"30","author":"Yeh","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R62-12-20210213","first-page":"397","article-title":"Direct medical cost of pelvic inflammatory disease and its sequelae: Decreasing, but still substantial.","volume":"95","author":"Rein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R63-12-20210213","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/01.olq.0000235148.64274.2f","article-title":"Productivity losses attributable to untreated infection with Chlamydia trachomatis and to associated pelvic inflammatory disease in reproductive-age women.","volume":"33","author":"Blandford","year":"2004","journal-title":"Sex Transm Dis"},{"key":"R64-12-20210213","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199509000-00002","article-title":"The Cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.","volume":"22","author":"Haddix","year":"1995","journal-title":"Sex Transm Dis"},{"key":"R65-12-20210213","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses.","volume":"36","author":"Gold","year":"1998","journal-title":"Med Care"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007435-200811001-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:35:54Z","timestamp":1618036554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-200811001-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e31818b64ac","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}